Skip to main content

Table 6 Summary of 7 kidney transplantation cases

From: Can we still ignore renal replacement therapy in sub-Saharan Africa? All living beings are created equal

 

Recipient

CDC

FlowPRA

 

Donor

Date of KT

Age

Sex

Blood type

Cause of ESRD

HLA mismatch

T cell

B cell

Class 1

Class 2

Latest Cr (μmol/L)

Age

Sex

Blood type

Relation

1

March 18

51

M

O Rh+

DM, HT

3/6

Neg

Neg

20%

20%

157

45

F

O Rh+

sister

2

August 18

46

F

AB Rh+

DM, HT

4/6

Neg

ND

8%

3%

97.3

48

F

B Rh+

sister

3

August 18

27

F

O Rh+

HT, RAS

6/6

Neg

ND

7%

6%

89.2

54

M

O Rh+

uncle

4

August 18

48

M

O Rh+

DM, HT

0/6

Neg

ND

29%

19%

108

41

M

O Rh+

brother

5

March 19

52

M

O Rh+

DM, HT

3/6

Neg

Neg

5%

0%

79.6

24

M

O Rh+

son

6

March 19

57

M

O Rh+

DM, HT

2/6

Neg

Neg

2%

0%

111

54

M

O Rh+

brother

7

March 19

36

M

O Rh+

CGN

2/6

Neg

Neg

3%

0%

105

46

M

O Rh+

brother

  1. CDC complement dependent cytotoxicity, PRA panel reactive antibody, KT kidney transplantation, ESRD endo-stage renal disease, HLA human leukocyte antigen, Cr creatinine, DM diabetes mellitus, HT hypertension, Neg negative, ND not done, RAS renal artery stenosis, CGN chronic glomerulonephritis, Latest Cr were measured in July 2019